Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study

被引：24
|
作者：
Moroni, Gabriella [1 ]
Gallelli, Beniamina [2 ]
Sinico, Renato Alberto [3 ,4 ]
Romano, Giulio [5 ]
Sinigaglia, Luigi [6 ]
Messa, Piergiorgio [1 ]
机构：
[1] Osped Maggiore, IRCCS Fdn Ca Granda, Div Nefrol & Dialisi, Milan, Italy
[2] Osped S Anna Como, Unita Nefrol & Dialisi, Como, Italy
[3] Azienda Osped Osped San Carlo Borromeo, Clin Immunol Unit, Milan, Italy
[4] Azienda Osped Osped San Carlo Borromeo, Renal Unit, Milan, Italy
[5] SM Misericordia Univ Hosp, Dept Nephrol, DISM, Udine, Italy
[6] Ist G Pini, Unita Operat Day Hosp, Dipartimento Reumatol, Milan, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2012年 / 71卷 / 10期
关键词：
ERYTHEMATOSUS; EFFICACY; THERAPY;
D O I：
10.1136/annrheumdis-2012-201442
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1751 / 1752
页数：2
相关论文
共 50 条
  • [1] Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
    Gunnarsson, Iva
    Sundelin, Birgitta
    Jonsdottir, Thorunn
    Jacobson, Stefan H.
    Henriksson, Elisabet Welin
    van Vollenhoven, Ronald F.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1263 - 1272
  • [2] Cyclophosphamide versus azathioprine for proliferative lupus nephritis therapy
    Nature Clinical Practice Nephrology, 2006, 2 (12): : 661 - 662
  • [3] A Retrospective Observational Study of Patients with Lupus Nephritis Treated with Rituximab in Combination with Cyclophosphamide
    Oliveira, Nidia
    Ibanez, Monica
    Ciang, Natalia
    Isenberg, David A.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Cyclophosphamide versus azathioprine for proliferative lupus nephritis therapy
    不详
    Nature Clinical Practice Rheumatology, 2006, 2 (11): : 661 - 662
  • [5] A preliminary study of tacrolimus versus cyclophosphamide in patients with diffuse proliferative lupus nephritis
    Hong, Ren
    Haijin, Yu
    Xianglin, Wang
    Cuilan, Hao
    Nan, Chen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 276 - 276
  • [6] Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study
    Moroni, Gabriella
    Raffiotta, Francesca
    Trezzi, Barbara
    Giglio, Elisa
    Mezzina, Nicoletta
    Del Papa, Nicoletta
    Meroni, Pierluigi
    Messa, Piergiorgio
    Sinico, Alberto Renato
    RHEUMATOLOGY, 2014, 53 (09) : 1570 - 1577
  • [7] Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
    Rovin, Brad H.
    Furie, Richard
    Latinis, Kevin
    Looney, R. John
    Fervenza, Fernando C.
    Sanchez-Guerrero, Jorge
    Maciuca, Romeo
    Zhang, David
    Garg, Jay P.
    Brunetta, Paul
    Appel, Gerald
    ARTHRITIS AND RHEUMATISM, 2012, 64 (04): : 1215 - 1226
  • [8] Azathioprine and cyclophosphamide in diffuse proliferative lupus nephritis treatment - A randomized controlled study
    Dyadyk, O. I.
    Vasilenko, I. V.
    Bagriy, A. E.
    Kholopov, L. S.
    Dyadyk, O. O.
    Yarovaya, N. F.
    Schulkina, O. V.
    Khomenko, M. V.
    Shpilevaya, N. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 467 - 467
  • [9] Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?
    Li, Edmund K.
    Tam, Lai-Shan
    Zhu, Tracy Y.
    Li, Martin
    Kwok, Catherine L.
    Li, Tena K.
    Leung, Ying Ying
    Wong, Kong Chiu
    Szeto, Cheuk Chun
    RHEUMATOLOGY, 2009, 48 (08) : 892 - 898
  • [10] Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study
    Onishi, Akira
    Sugiyama, Daisuke
    Tsuji, Go
    Nakazawa, Takashi
    Kogata, Yoshinori
    Tsuda, Kosaku
    Naka, Ikuko
    Nishimura, Keisuke
    Misaki, Kenta
    Kurimoto, Chiyo
    Hayashi, Hiroki
    Kageyama, Goichi
    Saegusa, Jun
    Sugimoto, Takeshi
    Kawano, Seiji
    Kumagai, Shunichi
    Morinobu, Akio
    MODERN RHEUMATOLOGY, 2013, 23 (01) : 89 - 96
12345